Evidence map›Paper›PMID 29707626›Full record

ArticleTransplantation direct2018

Single Graft Utilization From Donors With Severe Acute Kidney Injury After Circulatory Death.

Yusuke Tomita, Kazuhiro Iwadoh, Yuichi Ogawa, Katsuyuki Miki, Kotaro Kai, Akihito Sannomiya, Toru Murakami, Ichiro Koyama, Kumiko Kitajima, Ichiro Nakajima and 1 more

Abstract read
In one paragraph

Article in Transplantation direct, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Observational
  3. Observational
  4. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Yusuke TomitaTokyo Women's Medical University, Department of Surgery III, Tokyo, Japan.
Kazuhiro IwadohTokyo Women's Medical University, Department of Surgery III, Tokyo, Japan.
Yuichi OgawaTokyo Women's Medical University, Department of Surgery III, Tokyo, Japan.
Katsuyuki MikiTokyo Women's Medical University, Department of Surgery III, Tokyo, Japan.
Kotaro KaiTokyo Women's Medical University, Department of Surgery III, Tokyo, Japan.
Akihito SannomiyaTokyo Women's Medical University, Department of Surgery III, Tokyo, Japan.
Toru MurakamiTokyo Women's Medical University, Department of Surgery III, Tokyo, Japan.
Ichiro KoyamaTokyo Women's Medical University, Department of Surgery III, Tokyo, Japan.
Kumiko KitajimaTokyo Women's Medical University, Department of Surgery III, Tokyo, Japan.
Ichiro NakajimaTokyo Women's Medical University, Department of Surgery III, Tokyo, Japan.
Shohei FuchinoueTokyo Women's Medical University, Department of Surgery III, Tokyo, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chronic shortages of organs for transplantation have led to the use of marginal kidneys from donors after circulatory death with acute kidney injury (AKI), but the utilization of kidneys with severe AKI is not well established. We retrospectively analyzed eight kidney transplantation (KTx) cases from donation after circulatory death (DCD) with terminal creatinine (t-Cr) concentrations higher than 10.0 mg/dL and/or oliguria for more than 5 days (AKI network criteria: stage III). Although all patients showed delayed graft function, no cases of primary nonfunction (PNF) were found. Five patients maintained stable renal function for approximately 15.5, 10, 10, 5, and 0.5 years after KTx. Only 1 patient showed biopsy-proven acute rejection. Also, 2 patients developed graft failure: one attributable to chronic antibody mediated rejection at 11.3 years after KTx, and one attributable to recurrence of IgA nephropathy at 4.6 years after KTx. Kidneys with AKI stage III yielded great outcomes without the risk of primary nonfunction and rejection. Although the AKI kidneys were associated with delayed graft function, these results suggest that even the most severe kidneys with AKI stage III from DCD donors can be considered a valid alternative for recipients on a waiting list for KTx.

Identifiers

PMID29707626
PMCPMC5908460

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.